1. To understand the prognostic importance of post-procedural bleeding among patients undergoing
percutaneous coronary intervention (PCI).
2. To review the rationale underlying the use of P2Y12 inhibitor monotherapy following PCI.
3. To evaluate the safety and efficacy of antiplatelet de-escalation strategies. And, To determine the optimal
antithrombotic strategy in patient with atrial fibrillation and undergoing PCI.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation